PIK3CA and gastric cancer: To assess the anti-proliferative effects of a pan-class I PI3K inhibitor, NVP-BKM120, on human gastric cancer cells, we exposed 11 human gastric cancer cell lines with different modulations of PI3K/AKT cascade (Table I).